News in Health Tech
Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through approvals and commercialization.
Business Model:
Revenue: $41M
Employees: 51-200
Rankings
Industries / Tags:
Detailed News in Health Tech Information
News in Health Tech was acquired by
Celgene.
The acquisition happend on 2009-12-07.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 14 Broadway
City: Cambridge
State: MA
Zip: 02142-0010
Country: US
Financial Info
Stage:
series d
Raised Last:
$29M
Raised Total:$137M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Gloucester Pharmaceuticals is a biopharmaceutical company owned by [Celgene](/organization/celgene) that acquires clinical-stage oncology drug candidates with the goal of advancing them through regulatory approval and commercialization. Gloucester&s;s first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of hematological malignancies. The Company retains worldwide exclusive rights to romidepsin, an oncology candidate within a new class of anti-cancer agents known as histone deacetylase (HDAC) inhibitors. Preclinical studies suggest that romidepsin is a potent inhibitor of Class I, Class II and Class IV HDACs.
Contact Phone:
+16175831300
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2009 | Series D | 5 | $29M |
Prospect Venture Partners Novo Ventures Rho Capital Partners ProQuest Investments Apple Tree Partners Novo Ventures Prospect Venture Partners Novo Ventures Rho Capital Partners ProQuest Investments Apple Tree Partners Novo Ventures |
7/2009 | Debt Financing | $500k | 1/2008 | Convertible Note | $2M | 4/2009 | Debt Financing | $1.7M | 2/2009 | Convertible Note | $3M | 11/2008 | Series C | $5.3M | 2/2008 | Convertible Note | $4M | 7/2007 | Convertible Note | $2M | 5/2008 | Series C | $41.8M | 1/2006 | Convertible Note | $10M | 10/2004 | Series B | 5 | $29M |
Rho Ventures Prospect Venture Partners ProQuest Investments CIBC Capital Partners Apple Tree Partners Rho Ventures Prospect Venture Partners ProQuest Investments CIBC Capital Partners Apple Tree Partners |
4/2009 | Debt Financing | $1.5M | 4/2008 | Convertible Note | $2M | 10/2007 | Convertible Note | $5.3M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
